The
ALIC4E Trial:
Antivirals for influenza
Like
Illness? An r
Ct of
Clinical- and
Cost-effectiveness in primary
Car
E is the first publicly-funded randomised controlled trial of its kind to assess the (cost-)effectiveness of antiviral treatment for influenza in primary care.
At this final meeting we celebrated an incredible international achievement of having randomised 3268 participants into the ALIC4E study, which is part of the PREPARE Consortium, funded by the EU.